Procaps Group Receives Delisting Notice From Nasdaq

MIAMI and BARRANQUILLA, Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that the Company received a notice from The Nasdaq Stock Market LLC

February 3, 2025
Procaps Group Receives Additional Delinquency Letter
MIAMI and BARRANQUILLA , Columbia , Jan. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that, as anticipated, on December 31, 2024 , the Company received notice
January 3, 2025

Investor Contact Information

Company

Sofgen Pharma
9 Rue De Bitbourg
L-1273 Luxembourg
Grand Duchy of Luxembourg

Investor Relations

Sofgen Pharma Company Contact
ir@SofgenPharma.com

Search Investor Relations